Discover
IDYA
IDEAYA Biosciences, Inc.
37.32
2 x 37.29
1 x 37.35
bid
ask
+
0.58
1.59%
01:33 PM
timesize
| Ytd | 7.97% | |
| 1y | 63.41% |
36.02
day range
37.35
22.82
52 week range
40.58
| Open | 36.53 | Prev Close | 36.74 | Low | 36.02 | High | 37.35 | Mkt Cap | 3.55B |
| Vol | 206.95K | Avg Vol | 1.10M | EPS | -1.60 | P/E | -23.33 | Forward P/E | -9.01 |
| Beta | -0.10 | Short Ratio | 6.71 | Inst. Own | 102.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 34.32 | 200-d Avg | 32.96 | 1yr Est | 52.15 |
| Income Statement | |||
| Total Revenue | 8.86M | ||
| Revenues (USD) | 8.86M | ||
| Gross Profit | 8.86M | ||
| Operating Expenses | 131.15M | ||
| Research and Development Expense | 108.69M | ||
| Selling, General and Administrative Expense | 22.46M | ||
| Operating Income | -122.29M | ||
| Net Income | -112.45M | ||
| Net Income Common Stock | -112.45M | ||
| Net Income Common Stock (USD) | -112.45M | ||
| Consolidated Income | -112.45M | ||
| Earnings per Basic Share | -1.22 | ||
| Earnings per Basic Share (USD) | -1.22 | ||
| Earnings per Diluted Share | -1.22 | ||
| Earning Before Interest & Taxes (EBIT) | -112.45M | ||
| Earning Before Interest & Taxes (USD) | -112.45M | ||
| Weighted Average Shares | 92.06M | ||
| Weighted Average Shares Diluted | 92.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 273.87M | ||
| Cash and Equivalents (USD) | 273.87M | ||
| Investments | 970.30M | ||
| Investments Current | 556.37M | ||
| Investments Non-Current | 413.93M | ||
| Current Assets | 864.03M | ||
| Property, Plant & Equipment Net | 30.46M | ||
| Total Assets | 1.31B | ||
| Debt Current | 1.19M | ||
| Total Debt | 29.31M | ||
| Current Liabilities | 82.68M | ||
| Debt Non-Current | 28.12M | ||
| Total Liabilities | 110.79M | ||
| Accumulated Retained Earnings (Deficit) | -947.53M | ||
| Accumulated Other Comprehensive Income | -1.67M | ||
| Shareholders Equity | 1.20B | ||
| Shareholders Equity (USD) | 1.20B | ||
| Assets Non-Current | 445.67M | ||
| Total Debt (USD) | 29.31M | ||
| Liabilities Non-Current | 28.12M | ||
| Trade and Non-Trade Payables | 30.51M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.12M | ||
| Net Cash Flow from Financing | 359.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 115.07M | ||
| Capital Expenditure | -866.00K | ||
| Issuance (Purchase) of Equity Shares | 218.21M | ||
| Net Cash Flow from Investing | -155.93M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -155.07M | ||
| Net Cash Flow from Operations | -88.21M | ||
| Share Based Compensation | 16.66M | ||